We have seen cryptocurrency struggle ever since the U.S. SEC (Securities and Exchange Commission) declined the various firms’ attempts to launch a bitcoin ETFs.
While the chief of Securities and Exchange Commission's (SEC) Enforcement for Cryptocurrency and the Cyber Security Unit, Mr. Robert A. Cohen will step down in August after 15 years of long service, as per the sources. He will resign for his role as the executive enforcer for the cyber division established in 2017.
The Cyber division was in charge of securities violations of cryptocurrency and digital assets, furthermore, during his tenure, Cohen administered and investigated a number of cases, including legal prosecutions against the start-up Kik for unregistered $100 million token offerings, as per the official announcement by the SEC.
Amid various such developments, the US regulatory agency (SEC), has constantly shown its meticulous approach by denying the approval of an application filed by Cameron and Tyler Winklevoss, the reputed cryptocurrency investors and the founders of cryptocurrency exchange Gemini, to launch an exchange.


U.S. Treasury Yields Expected to Decline Amid Cooling Economic Pressures
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026
Moldova Criticizes Russia Amid Transdniestria Energy Crisis
Gold Prices Fall Amid Rate Jitters; Copper Steady as China Stimulus Eyed
Gold Cracks Below $4,500 as Safe-Haven Shine Fades; Technical Breakdown Signals Sell-on-Rallies Toward $4,000
US Economy Fueled by AI Investment Faces Rising Risks Ahead of Fed Meeting
Goldman Sachs Sees Stronger U.S. Dollar as Global Economic Gaps Widen
Ethereum Cracks Below $2,000 as Bitcoin Contagion Bites—Bearish EMA Stack Sets Sights on $1,700
Morgan Stanley Names Top AI Security and Data Center Stocks for 2026
Geopolitical Shocks That Could Reshape Financial Markets in 2025
Lithium Market Poised for Recovery Amid Supply Cuts and Rising Demand
FxWirePro- Major Crypto levels and bias summary
JPMorgan Sees Biotech Sector at Turning Point, Upgrades Top Pharma Stocks 



